The potential interest of topiramate in addiction
- Home
- The potential interest of topiramate in addiction
Topiramate is one of the currently most promising compounds in the field of addiction medicine. This paper discusses its potential utility related to a phase model of addiction development, focusing on the assumption that addiction is a continuous process involving different neurobiological pathways, depending on the stage of addiction. A specific emphasis will be made on the development of dysfunctional automatic behaviors in late stage of addiction and the central role of glutamate and AMPA receptors. The aim is to propose that if a too broad effect of anti-addiction medication is expected (such as anti-craving, anti-relapse and preventive effects), the results might be disappointing. The speculative specific efficacy of topiramate in addiction is described.
Synergy is the first and only entity in the GCC focused on Brain Health and Lifestyle Medicine services, in a multidisciplinary environment and through interdisciplinary collaboration.
Our approach is rooted in evidence-based practices that integrate medical science with holistic lifestyle strategies to achieve optimal health outcomes, aided by proprietary Neuro Technologies within our ecosystem.
Synergy's approach to healthy ageing is not loud, it is silently conducting the orchestra of the human mind, body and soul - because longevity is not the goal, it's the outcome.
Curious to know more? Scan the QR code and register so we can send you a complimentary pass to tune in to our interactive conference on Brain Health & Lifestyle Medicine - following our inauguration later this year!
Register Now
At Synergy, prevention meets purpose by empowering your mind and transforming your life